ID   MS-EwS-1
AC   CVCL_A0VK
SY   MS-PES-1; MSPES-1
DR   Wikidata; Q108820986
RX   PubMed=22374462;
RX   PubMed=24927333;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 18,22
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=22374462; DOI=10.1038/bjc.2012.57; PMCID=PMC3304425;
RA   Kailayangiri S., Altvater B., Meltzer J., Pscherer S., Luecke A.,
RA   Dierkes C., Titze U., Leuchte K., Landmeier S., Hotfilder M.,
RA   Dirksen U., Hardes J., Gosheger G., Juergens H., Rossig C.;
RT   "The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma
RT   and allows for MHC-independent immune targeting.";
RL   Br. J. Cancer 106:1123-1133(2012).
//
RX   PubMed=24927333; DOI=10.3892/or.2014.3269;
RA   Leuchte K., Altvater B., Hoffschlag S., Potratz J., Meltzer J.,
RA   Clemens D., Luecke A., Hardes J., Dirksen U., Juergens H.,
RA   Kailayangiri S., Rossig C.;
RT   "Anchorage-independent growth of Ewing sarcoma cells under serum-free
RT   conditions is not associated with stem-cell like phenotype and
RT   function.";
RL   Oncol. Rep. 32:845-852(2014).
//
RX   PubMed=29464090; DOI=10.18632/oncotarget.23815; PMCID=PMC5814230;
RA   Spurny C., Kailayangiri S., Altvater B., Jamitzky S., Hartmann W.,
RA   Wardelmann E., Ranft A., Dirksen U., Amler S., Hardes J., Fluegge M.,
RA   Meltzer J., Farwick N., Greune L., Rossig C.;
RT   "T cell infiltration into Ewing sarcomas is associated with local
RT   expression of immune-inhibitory HLA-G.";
RL   Oncotarget 9:6536-6549(2018).
//
RX   PubMed=30879952; DOI=10.1016/j.ymthe.2019.02.014; PMCID=PMC6520468;
RA   Kailayangiri S., Altvater B., Lesch S., Balbach S.T., Gottlich C.,
RA   Kuhnemundt J., Mikesch J.-H., Schelhaas S., Jamitzky S., Meltzer J.,
RA   Farwick N., Greune L., Fluegge M., Kerl K., Lode H.N., Siebert N.,
RA   Muller I., Walles H., Hartmann W., Rossig C.;
RT   "EZH2 inhibition in Ewing sarcoma upregulates GD2 expression for
RT   targeting with gene-modified T cells.";
RL   Mol. Ther. 27:933-946(2019).
//